| Phase 11 trial |
|
Phase 1
|
NCT00393276 |
Aug 2007 → Jul 2009 |
HIV infectious disease, hepatitis C virus infection |
National Institute of Allergy and Infectious Diseases (NIAID) |
Completed
|
No outcome recorded
|
| Phase 22 trials · 1 missed |
|
Phase 2
|
NCT00316303 |
Feb 2006 → Apr 2009 |
HIV infectious disease, bipolar disorder, depressive disorder, schizoaffective disorder +2 |
Dartmouth-Hitchcock Medical Center |
Completed
|
Mixed
|
|
Phase 2
|
NCT00107042 |
Feb 2004 → Jul 2008 |
hepatitis B virus infection |
University of North Carolina, Chapel Hill |
Completed
|
Missed primary
|
| Phase 34 trials |
|
Phase 3
|
NCT00465816 |
Apr 2007 → Apr 2008 |
meningococcal infection |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00451984 |
Mar 2007 → ? |
HIV infectious disease, hepatitis A virus infection, hepatitis B virus infection |
Aalborg University Hospital |
Unknown
|
No outcome recorded
|
|
Phase 3
|
NCT00289770 |
Nov → Dec 2004 |
hepatitis A virus infection, hepatitis B virus infection |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00289718 |
Nov 2004 → Mar 2005 |
hepatitis A virus infection, hepatitis B virus infection |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
| Phase 48 trials · 1 met primary |
|
Phase 4
|
NCT01451801 |
Oct 2011 → Jul 2013 |
hepatitis B virus infection |
University of Aarhus |
Unknown
|
No outcome recorded
|
|
Phase 4
|
NCT01126853 |
Apr 2010 → Jun 2011 |
hepatitis B virus infection |
Mount Sinai Hospital, Canada |
Withdrawn
|
No outcome recorded
|
|
Phase 4
|
NCT00684671 |
May → Nov 2008 |
hepatitis A virus infection, hepatitis B virus infection |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT00603252 |
Jan → Jun 2008 |
hepatitis A virus infection, hepatitis B virus infection |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT00142753 |
Aug 2005 → Nov 2007 |
HIV infectious disease |
University of North Carolina, Chapel Hill |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT00186836 |
Nov 2004 → Nov 2006 |
hepatitis B virus infection |
St. Joseph's Health Care London |
Completed
|
Met primary
|
|
Phase 4
|
NCT00216229 |
Sep 2004 → Feb 2006 |
— |
IDEWE Occupational Health Services |
Unknown
|
No outcome recorded
|
|
Phase 4
|
NCT00289731 |
Nov 2003 → Dec 2004 |
hepatitis A virus infection, hepatitis B virus infection |
GlaxoSmithKline |
Completed
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT00244374 |
Aug 2004 → Jun 2008 |
hepatitis A virus infection, hepatitis B virus infection, hepatitis C virus infection, substance abuse |
University of California, San Francisco |
Completed
|
No outcome recorded
|
| Comparator or background therapy3 trials |
|
Phase 1
|
NCT02334462 Comparator |
Jan 2015 → Mar 2016 |
malaria |
National Institute of Allergy and Infectious Diseases (NIAID) |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT00106964 Comparator |
Jan 2004 → Jan 2008 |
HIV infectious disease, hepatitis B virus infection |
University of North Carolina, Chapel Hill |
Completed
|
No outcome recorded
|
|
Phase 4
|
NCT01259453 Comparator |
May 2003 → Aug 2006 |
hepatitis B virus infection |
Yale University |
Completed
|
No outcome recorded
|